本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Inozyme Pharma

0.9600
-0.0206-2.10%
盘后0.98000.0200+2.08%19:33 EDT
成交量:52.35万
成交额:50.38万
市值:6,167.06万
市盈率:-0.59
高:0.9951
开:0.9825
低:0.9413
收:0.9806
数据加载中...
2023/07/28

重要事件披露

Form 8-K - Current report
2023/07/26

重要事件披露

Form 8-K - Current report
2023/06/30

SEC问询函

Form CORRESP - Correspondence
2023/06/28

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/06/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/22

重要事件披露

8-K - Current report
2023/03/22

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/10

重要事件披露

8-K - Current report
2023/03/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/16

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals